✦ LIBER ✦

Quadruple alkylating agent therapy with ABMR for advanced non small cell lung cancer (NSCLC)

Book ID: 122612151
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 180 KB
Volume: 2
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(86)80512-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advanced Non-Small Cell Lung Cancer (NSC

Advanced Non-Small Cell Lung Cancer (NSCLC): Maintenance Therapy for All?

✍ Hashemi-Sadraei, Nooshin; Pennell, Nathan A. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 169 KB

Ifosfamide bolus therapy for advanced no

Ifosfamide bolus therapy for advanced non small cell lung cancer (NSCLC)

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Chemotherapy for advanced non-small cell

Chemotherapy for advanced non-small cell lung cancer (NSCLC)

✍ Manegold, Christian 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Double alkylating agent therapy with ifo

Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group

✍ Nick Thatcher; David B. Smith; Mike J. Lind; Heather Anderson; Joyce Barclay; Ma 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

Combined modality therapy for advanced s

Combined modality therapy for advanced stage III non small cell lung cancer (NSCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Multimodality therapy for locally advanc

Multimodality therapy for locally advanced stage IIIA-B non-small cell lung cancer (NSCLC)

✍ Zharkov, V; Kurchin, V; Moiseev, P 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 255 KB